• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有门静脉受累的胰腺癌——我们采用改良切除技术的经验

Carcinoma of the pancreas with portal vein involvement--our experience with a modified technique of resection.

作者信息

Jain Sundeep, Sacchi M, Vrachnos P, Lygidakis N J

机构信息

Department of Surgical Oncology, Henry Dunant Hospital, Athens, Greece.

出版信息

Hepatogastroenterology. 2005 Sep-Oct;52(65):1596-600.

PMID:16201124
Abstract

BACKGROUND/AIMS: Up to 40% of the patients with pancreatic carcinoma are not fit for curative resection due to the locally advanced nature of the disease in the form of vascular involvement. In recent years a more aggressive approach of vascular resection with pancreaticoduodenectomy (PD) has resulted in the increase in resectability rate and survival in this group of patients. The most important determinant of survival in these patients is negative resection margins. The aim of the present study is to present our experience of vascular resection using a modified technique, in patients with pancreatic cancer.

METHODOLOGY

This is a retrospective study of 48 patients who underwent portal vein/superior mesenteric vein (PV/SMV) resection along with PD using the modified technique of resection, during 1982-2004. The principle modification is the initial extensive retroperitoneal dissection for the assessment of the extent of tumor involvement of the superior mesenteric vessels and division of retroperitoneal margin before the division of the pancreas. All patients also underwent extended lymphadenectomy.

RESULTS

The subtotal PD was done in 26 and total PD in 22 patients, with resection of the PV/SMV in all of them. The end-to-end anastomosis was possible after adequate mobilization of the PV and SMV in 40 patients. In 4 patients reconstruction was able to be done with the use of a graft. The portal vein occlusion time was 8-15 minutes. Histopathological examination showed negative margins in all the resected specimens. Postoperative complications occurred in 16.66% with reoperation rate of 8.33%, and mortality of 6.25%. After a mean follow-up of 110 months, mean survival was 40 months with the range of 18-250 months. The five-year and 10-year survival was 18% and 10% respectively. The venous patency rate was 100% at three years.

CONCLUSIONS

In conclusion, PD with en bloc resection of the PV/SMV confluence can safely be done with morbidity and mortality similar to that of standard PD. The survival advantage is directly related to the attainment of negative resection margins. The modified technique is a useful way of doing vascular resection with the least amount of bowel congestion and securing negative resection margins.

摘要

背景/目的:高达40%的胰腺癌患者因疾病局部进展累及血管而不适合进行根治性切除。近年来,采用更积极的血管切除联合胰十二指肠切除术(PD)的方法,使这组患者的可切除率和生存率有所提高。这些患者生存的最重要决定因素是切缘阴性。本研究的目的是介绍我们采用改良技术对胰腺癌患者进行血管切除的经验。

方法

这是一项回顾性研究,对1982年至2004年间48例行门静脉/肠系膜上静脉(PV/SMV)切除联合PD并采用改良切除技术的患者进行分析。主要改良之处在于最初进行广泛的腹膜后解剖,以评估肠系膜上血管受肿瘤累及的范围,并在胰腺离断前先离断腹膜后切缘。所有患者均行扩大淋巴结清扫术。

结果

26例行保留幽门的胰十二指肠切除术,22例行经典胰十二指肠切除术,所有患者均切除PV/SMV。40例患者在充分游离PV和SMV后可行端端吻合。4例患者需用移植物进行重建。门静脉阻断时间为8 - 15分钟。组织病理学检查显示所有切除标本切缘阴性。术后并发症发生率为16.66%,再次手术率为8.33%,死亡率为6.25%。平均随访110个月,平均生存期为40个月,范围为18 - 250个月。5年和10年生存率分别为18%和10%。三年时静脉通畅率为100%。

结论

总之,联合PV/SMV汇合部整块切除的PD可以安全进行,其发病率和死亡率与标准PD相似。生存优势直接与获得阴性切缘相关。改良技术是进行血管切除的一种有用方法,可使肠管充血最少并确保切缘阴性。

相似文献

1
Carcinoma of the pancreas with portal vein involvement--our experience with a modified technique of resection.伴有门静脉受累的胰腺癌——我们采用改良切除技术的经验
Hepatogastroenterology. 2005 Sep-Oct;52(65):1596-600.
2
Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.胰十二指肠切除术后门静脉切除后假体移植重建:多中心分析。
J Am Coll Surg. 2010 Sep;211(3):316-24. doi: 10.1016/j.jamcollsurg.2010.04.005. Epub 2010 Jun 8.
3
Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.胰十二指肠切除术联合切除肠系膜上静脉-门静脉汇合部治疗胰头腺癌后的生存情况。
Br J Surg. 1998 May;85(5):611-7. doi: 10.1046/j.1365-2168.1998.00641.x.
4
Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.胰十二指肠切除术中门静脉或肠系膜上静脉的节段性切除和楔形切除。
Surgery. 2001 Feb;129(2):158-63. doi: 10.1067/msy.2001.110221.
5
Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection.胰头腺癌门静脉或肠系膜上静脉切除:静脉切除长度的预后价值
Surgery. 2009 Apr;145(4):417-25. doi: 10.1016/j.surg.2008.12.009. Epub 2009 Feb 23.
6
Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.胰头癌胰十二指肠切除术中门静脉-肠系膜上静脉切除的临床意义。
Pancreas. 2012 Jan;41(1):102-6. doi: 10.1097/MPA.0b013e318221c595.
7
Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?在胰十二指肠切除术治疗腺癌时是否应常规切除门静脉?
Ann Surg. 2013 Apr;257(4):726-30. doi: 10.1097/SLA.0b013e318269d23c.
8
Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.单一癌症研究所对肝胆胰疾病患者进行的肝切除及联合血管切除的胰腺切除术
Hepatogastroenterology. 2008 May-Jun;55(84):873-8.
9
En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.局部晚期浸润主要血管的胰腺恶性肿瘤的整块血管切除术:136例患者的围手术期结局和长期生存情况
Ann Surg. 2008 Feb;247(2):300-9. doi: 10.1097/SLA.0b013e31815aab22.
10
Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy.胰头癌扩大淋巴结清扫术及静脉切除术:疗效及对治疗的意义
Arch Surg. 2003 Dec;138(12):1316-22. doi: 10.1001/archsurg.138.12.1316.

引用本文的文献

1
Comparison between long and short-term venous patencies after pancreatoduodenectomy or total pancreatectomy with portal/superior mesenteric vein resection stratified by reconstruction type.比较不同重建类型胰十二指肠切除术或全胰切除术联合门静脉/肠系膜上静脉切除术后静脉通畅的长期和短期效果。
PLoS One. 2020 Nov 5;15(11):e0240737. doi: 10.1371/journal.pone.0240737. eCollection 2020.
2
[Vascular surgical aspects in abdominal surgery : Results from a tertiary care center over a 10-year time period].[腹部手术中的血管外科问题:一家三级医疗中心10年期间的结果]
Chirurg. 2019 Apr;90(4):307-317. doi: 10.1007/s00104-018-0726-y.
3
Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?
胰十二指肠切除术时的静脉累及:是否需要重新定义“边界可切除性疾病”?
J Gastrointest Surg. 2013 Jul;17(7):1209-17; discussion 1217. doi: 10.1007/s11605-013-2178-5. Epub 2013 Apr 26.
4
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.肠系膜上静脉/门静脉的组织学肿瘤侵犯预示着接受新辅助放化疗的 II 期胰腺腺癌患者预后不良。
Cancer. 2012 Aug 1;118(15):3801-11. doi: 10.1002/cncr.26717. Epub 2011 Dec 16.
5
Combined pancreaticoduodenectomy and extended right hemicolectomy: outcomes and indications.胰十二指肠切除术联合扩大右半结肠切除术:疗效和适应证。
HPB (Oxford). 2009 Nov;11(7):559-64. doi: 10.1111/j.1477-2574.2009.00087.x.
6
Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review.扩展胰十二指肠切除术联合血管切除治疗胰腺癌:一项系统评价。
J Gastrointest Surg. 2010 Sep;14(9):1442-52. doi: 10.1007/s11605-009-1129-7. Epub 2010 Apr 9.
7
Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma.Ⅱ期胰腺癌整块血管切除的预后和可行性。
World J Gastroenterol. 2010 Feb 28;16(8):997-1002. doi: 10.3748/wjg.v16.i8.997.
8
Clinical and pathologic prognostic factors for curative resection for pancreatic cancer.胰腺癌根治性切除的临床和病理预后因素。
HPB (Oxford). 2008;10(5):356-62. doi: 10.1080/13651820802140752.
9
Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors.两家欧洲中心行胰腺切除术时的血管切除术结果:生存和无病生存解释因素分析。
HPB (Oxford). 2006;8(6):465-73. doi: 10.1080/13651820600839944.